The company is comprised of seasoned drug developers with sound experience in discovery, preclinical research, clinical development, and scientific management expertise. With the team's well-acknowledged expertise and track records, Angitia is positioned to be the leading biopharmaceutical company in musculoskeletal diseases by bringing transformative therapeutics to patients in need.